CAR-Expressing Natural Killer Cells for Cancer Retargeting

Since the approval in 2017 and the outstanding success of Kymriah® and Yescarta®, the number of clinical trials investigating the safety and efficacy of chimeric antigen receptor-modified autologous T cells has been constantly rising. Currently, more than 200 clinical trials are listed on clinicaltr...

Full description

Saved in:
Bibliographic Details
Published inTransfusion medicine and hemotherapy Vol. 46; no. 1; pp. 4 - 13
Main Authors Kloess, Stephan, Kretschmer, Anna, Stahl, Lilly, Fricke, Stephan, Koehl, Ulrike
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.02.2019
Subjects
Online AccessGet full text

Cover

Loading…